AtriCure, Inc (United States) is listed on the Nasdaq and has a market capitalization of $2.15 billion, with shareholders equity totaling $516.43 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, AtriCure, Inc reported $569.62 million in revenue, generating net income of $10.56 million.
Key financial metrics include a P/E ratio of 203.29, a price-to-book (P/B) ratio of 4.16, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ATRC.